(Q38488050)

3 September 2017

title

Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset (English)

1 reference

3 September 2017

J H Moon

1 reference

3 September 2017

S N Kim

1 reference

3 September 2017

B W Kang

1 reference

3 September 2017

Y S Chae

1 reference

3 September 2017

J G Kim

1 reference

3 September 2017

J S Ahn

1 reference

3 September 2017

Y K Kim

1 reference

3 September 2017

D H Yang

1 reference

3 September 2017

J J Lee

1 reference

3 September 2017

H J Kim

1 reference

3 September 2017

Y J Choi

1 reference

3 September 2017

H J Shin

1 reference

3 September 2017

J S Chung

1 reference

3 September 2017

G J Cho

1 reference

3 September 2017

S K Sohn

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

Bone Marrow Transplantation

3 September 2017

1 reference

inferred from page(s)

published in

1 reference

3 September 2017

1 reference

3 September 2017

1 reference

3 September 2017

page(s)

1540-1545

1 reference

Immunobiology of allogeneic hematopoietic stem cell transplantation

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

New approaches for preventing and treating chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

Chronic graft-versus-host disease: where is promise for the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

Pathophysiology of acute graft-versus-host disease: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

Immunobiology of acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

The pathophysiology and treatment of graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Hyperacute GVHD: risk factors, outcomes, and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Cellular and cytokine effectors of acute graft versus host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Donor APCs are required for maximal GVHD but not for GVL

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Detection and long-term in vivo monitoring of individual tumor-specific T cell clones in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.12

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.12

1 reference

Dimensions Publication ID

3 September 2017

1002394480

0 references

1 reference